pamidronate and interleukin-8

pamidronate has been researched along with interleukin-8 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avvisati, G; Battistoni, F; Denaro, V; Dicuonzo, G; Gavasci, M; Salerno, A; Santini, D; Tonini, G; Vincenzi, B	1
Barken, I; Burton, DW; Deftos, LJ; Geller, J; Hastings, RH; Hoffman, RM; Jiang, P; Yang, M	1

Trials

1 trial(s) available for pamidronate and interleukin-8

Article	Year
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:5 Topics: Aged; Angiogenesis Inducing Agents; Antineoplastic Agents; Cytokines; Diphosphonates; Endothelial Growth Factors; Female; Humans; Interferon-gamma; Interleukin-6; Interleukin-8; Linear Models; Lymphokines; Male; Middle Aged; Neoplasms; Pamidronate; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002

Article

Year

Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:5

Topics: Aged; Angiogenesis Inducing Agents; Antineoplastic Agents; Cytokines; Diphosphonates; Endothelial Growth Factors; Female; Humans; Interferon-gamma; Interleukin-6; Interleukin-8; Linear Models; Lymphokines; Male; Middle Aged; Neoplasms; Pamidronate; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002

Other Studies

1 other study(ies) available for pamidronate and interleukin-8

Article	Year
Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP. The Prostate, 2005, Feb-15, Volume: 62, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Calcium; Carrier Proteins; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Glycoproteins; Green Fluorescent Proteins; Humans; Interleukin-6; Interleukin-8; Male; Membrane Glycoproteins; Mice; Mice, SCID; Microscopy, Fluorescence; Osteoprotegerin; Pamidronate; Parathyroid Hormone-Related Protein; Prostatic Neoplasms; Radiography; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Transduction, Genetic	2005

Article

Year

Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP.

The Prostate, 2005, Feb-15, Volume: 62, Issue:3

Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Calcium; Carrier Proteins; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Glycoproteins; Green Fluorescent Proteins; Humans; Interleukin-6; Interleukin-8; Male; Membrane Glycoproteins; Mice; Mice, SCID; Microscopy, Fluorescence; Osteoprotegerin; Pamidronate; Parathyroid Hormone-Related Protein; Prostatic Neoplasms; Radiography; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Transduction, Genetic

2005